ipamorelin or cjc 1295 No DAC – Blend 5mg/5mg – NewBioRx Blog - Renew Vitality

A reasonable range of clinical considerations for dosing: Nominal dose per spray varies by compounding pharmacy preparation

Who is an Ideal Candidate

The ipamorelin dosage used in medical settings and clinical trials is 0.03 mg per kg of body weight administered intravenously twice daily

Who Typically Looks Into CJC-1295 Individuals researching CJC 1295 are often looking to: Improve body composition and reduce fat mass Recover faster from training or injury Restore vitality and sleep quality associated with age related GH decline Support joint, tendon, and skin health Although CJC 1295 may seem appealing for these goals, the peptides research status and lack of FDA approval for general use make it unsuitable for self administration

It is short-acting pharmacologically much closer to sermorelin than to the DAC version and clears within minutes

This creates smaller individual GH pulses that may be more tolerable